ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Mindmaze Therapeutics Holding SA (QB)

Mindmaze Therapeutics Holding SA (QB) (RLFTY)

0,4225
0,00
(0,00%)
Geschlossen 03 Juli 10:00PM

Mindmaze Therapeutics Holding SA (QB) (RLFTY) Aktie

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Premium

Wichtige Statistiken und Details

Current Price
0,4225
( - )
Gebot
0,3556
Fragen
4,17
Volumen
-
0,00 Tagesbereich 0,00
0,2461 52-Wochen-Bereich 4,90
Marktkapitalisierung
Handelsende
0,4225
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
US$ 1.297.793
Ausgegebene Aktien
152.602.044
Dividendenrendite (LTM)
Kurs-Gewinn-Verhältnis
-0,42
Gewinn pro Aktie (EPS)
-0,48
Erlöse (LTM)
642k
Nettogewinn (LTM)
-9,91M

Über Mindmaze Therapeutics Holding SA (QB)

MindMaze Therapeutics Holding SA operates as a commercial-stage biopharmaceutical and neurotechnology company in Asia, the United States, Switzerland, rest of Europe, and internationally. The company offers MindPod system, a supervised in-clinic neurorehabilitation system designed to initiate and in... MindMaze Therapeutics Holding SA operates as a commercial-stage biopharmaceutical and neurotechnology company in Asia, the United States, Switzerland, rest of Europe, and internationally. The company offers MindPod system, a supervised in-clinic neurorehabilitation system designed to initiate and intensify the recovery journey; MindMotion GO, which extends protocolized neurotherapeutics into outpatient and home settings; MindMotion Companion, an application that manages prescription, monitoring and documentation across MindMaze Therapeutics’ neurotherapeutics ecosystem; and the patient app, a patient-facing mobile application, that supports clinic-to-home continuity by making prescribed therapy easy to follow outside the clinic. It also provides Izar hand therapy device which supports fine motor rehabilitation; Physilog sensor, a wearable inertial sensing device designed to quantify human movement; toaprun, a training for Parkinson’s therapy-reimagined through play. The company was founded in 2012 and is headquartered in Geneva, Switzerland. Mehr anzeigen

Sektor
Healthcare
Branche
Biotechnology & Life Sciences
Hauptsitz
Geneva, Switzerland
Gegründet
2026
Mindmaze Therapeutics Holding SA (QB) is listed in the Healthcare sector of the OTC Markets with ticker RLFTY. The last closing price for Mindmaze Therapeutics (QB) was US$0,42. Over the last year, Mindmaze Therapeutics (QB) shares have traded in a share price range of US$ 0,2461 to US$ 4,90.

Mindmaze Therapeutics (QB) currently has 152.602.044 shares in issue. The market capitalisation of Mindmaze Therapeutics (QB) is US$64,47 million. Mindmaze Therapeutics (QB) has a price to earnings ratio (PE ratio) of -0.42.

RLFTY Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000DR
40000000DR
12-1.9775-82.39583333332.42.40.246113290.49615717DR
26-2.3975-85.01773049652.824.050.246110651.48395357DR
52-2.5775-85.916666666734.90.246111943.00871431DR
156-2.6313-86.1647783093.05387.710.246121882.58442098DR
260-14.5775-97.18333333331517.90.246117093.16493489DR

RLFTY - Frequently Asked Questions (FAQ)

What is the current Mindmaze Therapeutics Holding SA (QB) share price?
The current share price of Mindmaze Therapeutics Holding SA (QB) is US$ 0,4225
How many Mindmaze Therapeutics Holding SA (QB) shares are in issue?
Mindmaze Therapeutics Holding SA (QB) has 152.602.044 shares in issue
What is the market cap of Mindmaze Therapeutics Holding SA (QB)?
The market capitalisation of Mindmaze Therapeutics Holding SA (QB) is USD 64,47M
What is the 1 year trading range for Mindmaze Therapeutics Holding SA (QB) share price?
Mindmaze Therapeutics Holding SA (QB) has traded in the range of US$ 0,2461 to US$ 4,90 during the past year
What is the PE ratio of Mindmaze Therapeutics Holding SA (QB)?
The price to earnings ratio of Mindmaze Therapeutics Holding SA (QB) is -0,42
What is the cash to sales ratio of Mindmaze Therapeutics Holding SA (QB)?
The cash to sales ratio of Mindmaze Therapeutics Holding SA (QB) is 47,54
What is the registered address of Mindmaze Therapeutics Holding SA (QB)?
The registered address for Mindmaze Therapeutics Holding SA (QB) is Avenue de Sécheron 15, Geneva, 1202
What is the Mindmaze Therapeutics Holding SA (QB) website address?
The website address for Mindmaze Therapeutics Holding SA (QB) is mindmazetherapeutics.com
Which industry sector does Mindmaze Therapeutics Holding SA (QB) operate in?
Mindmaze Therapeutics Holding SA (QB) operates in the Biotechnology & Life Sciences sector

RLFTY Trades

Mehr

Trades verzögert

Um Echtzeit-Trades zu erhalten, aktualisieren Sie Ihr Konto

Auf Echtzeit aktualisieren
Keine Diskussionen Gefunden.
Neuen Thread Erstellen